Literature DB >> 12735423

Tension pneumopericardium caused by positive pressure ventilation complicating anaerobic pneumonia.

C P Bleeker-Rovers1, F J J van den Elshout, T I F M Bloemen, H A H Kaasjager.   

Abstract

A 22-year-old man was admitted with pneumonia. He was immediately intubated and positive pressure ventilation was initiated. Blood and sputum cultures showed Bacteroides fragilis and Corynebacterium sp., which were treated with metronidazole and clindamycin. Three weeks later his blood pressure suddenly dropped with an elevation of the central venous pressure. Chest X-ray revealed a pneumopericardium. A parasternal mediastinotomy with partial pericardiectomy was immediately performed. On opening the pericardium his blood pressure normalised. The patient gradually recovered and six weeks after admission he was extubated. Two weeks later he was discharged. A pneumopericardium without previous thorax trauma is very rare and early recognition is imperative because a tension pneumopericardium with cardiac tamponade may develop, as happened in this case. A tension pneumopericardium has to be treated with immediate pericardiocentesis followed by partial pericardiectomy to avoid recurrence.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12735423

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  3 in total

1.  Spontaneous pneumopericardium in a dog with bronchopulmonary disease complicated by pyothorax and pneumothorax.

Authors:  Simone Borgonovo; Paola M Rocchi; Vera Raiano; Daniela Diana; Valentina Greci
Journal:  Can Vet J       Date:  2014-12       Impact factor: 1.008

2.  Mediastinoscope-controlled parasternal fenestration of the pericardium: definitive surgical palliation of malignant pericardial effusion.

Authors:  Imre Toth; Geza Szucs; Tamas F Molnar
Journal:  J Cardiothorac Surg       Date:  2012-06-19       Impact factor: 1.637

3.  Cardiac tamponade due to pneumopericardium.

Authors:  Yuansheng Xu; Zhijun Xu; Yi Wang
Journal:  Pak J Med Sci       Date:  2014-07       Impact factor: 1.088

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.